Breaking News
2017 – Amolab winner of Horizon 2020 SME Instrument Grant for Phase 1
The European Commision has selected “SensUS :A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process” for funding through the Research […]
Amolab partecipated at MEDICA 2017 (13-16 November, Düsseldorf, Germany)
World Forum for Medicine: the world’s leading trade fair for the medical industry https://www.medica-tradefair.com/
AMOLAB partecipated at FMF 2017 ( 25-29 June, Ljubljana, Slovenia)
16th World Congress in Fetal Medicine https://fetalmedicine.org/
Amolab partecipated at ICRHC 2017 (20-22 May, Tehran, Iran)
The 2nd International Congress on Reproductive Health and Childbearing http://www.icrhc-iserb.ir/2017/en/icrhc2017/about
Quantitative ultrasound for childbirth monitoring
Safer childbirth with SensUS the new QUS device for midwives and gynecologists
SensUS is an echographic portable medical device, endowed with an innovative software application (Amolab Suite) allowing a safe and quantitative monitoring of childbirth, in real time, through an automatic elaboration of theacquired echographic images.
In a few seconds it is now possible to safely andreliably assess the fetal progress in the birth canal.The Implemented algorithms are the most advanced synthesis of ultrasonic technologies available in medicine.They allow a simple and continuous monitoring of childbirth labor, automatically providing quantitativeand accurate measurements of the most important indicators of fetal progression.
Our mission
Amolab’s mission is to provide to the medical community the first solution for a quantitative, automatic, non-invasiveand safe monitoring of labor. Amolab offers clinicians an objectiveand reliable tool to assess fetal wellbeing from intrauterine to extrauterine life.Fetal progression through the birth canal may be now automatically assessed and objectively quantified avoiding operator dependence, thus drastically decreasing human error rates. Finally, midwives and gynecologists will be supported by an effective, innovative, and easy to use medical device.
